BioTime completes direct public offering

BioTime Inc. (NYSE-M:BTX), Alameda, Calif. Business: Gene/Cell therapy, Pulmonary, Diagnostic Date completed: 2014-10-09 Type: Direct public offering Raised: $29.4 million Shares: 9.4 million Price: $...